Rapid molecular testing for clinical diagnostics
Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes molecular testing to a new level of easiness and speed without compromising the quality of results.
Cost efficient automated solution
All-in-one PCR and RT-PCR test chips with homogeneous detection in fully automated instrument.
Reducing the costs by affordable pricing, robust assays and long service intervals.
CE IVD tests for infectious diseases
Critical human pathogens and antibiotic resistance markers such as C. difficile, Norovirus and MRSA
GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx.
Results shows equal sensitivity to culture and article highlights the usability of GenomEra.
From the conclusions: “GenomEra GBS PCR assay has potential as an easy and rapid on-site test for intrapartum detection of vaginal carriage of GBS at a maternity ward to identify women in labor who should receive intrapartum antibiotic prophylaxis.”
Abacus Diagnostica´s GenomEra Flu A/B + RSV is now CE IVD approved and available! To discuss more about our new product, come and meet us at ECCMID 2019 in Amsterdam, booth 1.148!
Analyte PPA (i.e. sensitivity) NPA (i.e. specificity) Accuracy
Flu A (n=1256) 97.1% 99.4% 98.6%
Flu B (n=1256) 100% 100% 100%
RSV (n=701) 98% 99.8% 98.7%
Overall accuracy: 99.3%
Abacus Diagnostica is exhibiting at ECCMID 2019. Contact us to book your meeting with the team to hear the latest news! See you in few weeks at booth #1.148!